Global GMP Peptide Manufacturing Services Supply, Demand and Key Producers, 2026-2032
The global GMP Peptide Manufacturing Services market size is expected to reach $ 11201 million by 2032, rising at a market growth of 18.5% CAGR during the forecast period (2026-2032).
GMP Peptide Manufacturing Services refer to manufacturing services for therapeutic peptide active pharmaceutical ingredients under GMP-compliant conditions, covering process confirmation, scale-up production, validation batches, registration batches, and commercial supply, with a strong focus on product quality, batch consistency, traceability, and regulatory compliance. This segment is typically based on solid-phase peptide synthesis, liquid-phase fragment coupling, and subsequent purification, lyophilization, and packaging operations. Its upstream supply chain mainly includes protected amino acids, specialty amino acids, resin supports, coupling reagents, cleavage and deprotection reagents, organic solvents, purification media, analytical consumables, and GMP packaging materials, while the main downstream customers are innovative pharmaceutical companies, biotechnology firms, specialty generic drug developers, and drug manufacturers that further formulate peptide APIs into injectables, lyophilized products, or other dosage forms. This type of service requires a high standard of manufacturing control, batch-to-batch consistency, impurity profile management, documentation systems, and reliable long-term supply. The global gross margin of GMP Peptide Manufacturing Services in 2025 is estimated at 25%-40%.
The GMP peptide manufacturing services market is undergoing a structural upgrade, supported by rapid demand expansion and rising technical requirements. Historically, peptide manufacturing was mainly driven by traditional short peptides, generic peptide APIs, and small clinical-stage projects, with competition centered on synthesis experience, quality systems, purification capability, and regulatory support. In recent years, GLP-1 therapeutics, long-acting modified peptides, complex cyclic peptides, constrained peptides, peptide conjugates, and personalized peptide vaccines have significantly increased demand for GMP-grade synthesis, scale-up, purification, lyophilization, and analytical development. Leading CDMOs benefit from commercial project experience, global pharmaceutical customer relationships, and multi-regional capacity layouts, while suppliers in China, India, and Japan are accelerating their participation through GMP capacity expansion, TIDES platform development, and stronger local supply chains. Future growth will be primarily driven by the expansion of innovative peptide pipelines and the commercialization of high-volume peptide drugs. Applications in metabolic diseases, oncology and immunotherapy, rare diseases, infectious diseases, and peptide conjugate therapies continue to encourage pharmaceutical companies to outsource peptide API development and manufacturing to specialized service providers. Compared with small-molecule APIs, peptide manufacturing involves higher complexity in sequence design, protecting group strategy, impurity profiling, yield optimization, and batch-to-batch consistency. Building in-house peptide manufacturing capacity requires substantial capital investment and deep process expertise, which supports a continued increase in outsourcing penetration. At the same time, pharmaceutical customers are placing greater emphasis on supply security and regulatory compliance, pushing peptide CDMOs to evolve from standalone synthesis providers into integrated partners covering process development, analytical methods, registration batches, validation batches, and commercial supply. From a technology perspective, solid-phase peptide synthesis remains the mainstream route for complex and long-chain peptides, while liquid-phase synthesis and hybrid solid-liquid strategies remain valuable for selected short peptides, large-volume commercial products, and cost-sensitive programs. As project scale increases, preparative chromatography, continuous purification, solvent recovery, green chemistry, automated synthesis, lyophilization efficiency, and high-purity impurity control will become key areas of differentiation. Service providers with capabilities in complex modification, lipidation, cyclization, fragment condensation, incorporation of non-natural amino acids, and peptide-drug conjugation will be better positioned to participate in high-value innovative drug programs. Future competition will not be defined by capacity alone, but by the combined strength of process platforms, quality systems, cost control, and global delivery capabilities. The industry still faces several constraints. Peptide manufacturing relies heavily on resins, protected amino acids, coupling reagents, high-purity solvents, and preparative purification equipment. Volatility in raw material prices, stricter environmental requirements, and rising solvent treatment costs may pressure margins for some suppliers. Rapid commercialization of large-volume peptide drugs may create temporary capacity shortages, but concentrated capacity expansion by multiple companies could also lead to price competition in less complex product segments. In parallel, global pharmaceutical regulators continue to raise expectations for impurity control, residual solvents, data integrity, and supply chain traceability, creating higher barriers for smaller manufacturers in audits, validation, and international regulatory documentation. Overall, GMP peptide manufacturing services remain a high-growth market, but industry polarization is likely to become more pronounced, with platform-based leaders and specialized technology-driven manufacturers gaining more stable long-term opportunities.
This report studies the global GMP Peptide Manufacturing Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for GMP Peptide Manufacturing Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GMP Peptide Manufacturing Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GMP Peptide Manufacturing Services total market, 2021-2032, (USD Million)
Global GMP Peptide Manufacturing Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: GMP Peptide Manufacturing Services total market, key domestic companies, and share, (USD Million)
Global GMP Peptide Manufacturing Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global GMP Peptide Manufacturing Services total market by Type, CAGR, 2021-2032, (USD Million)
Global GMP Peptide Manufacturing Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global GMP Peptide Manufacturing Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PolyPeptide, Bachem, AmbioPharm, CordenPharma, Piramal Pharma Solutions, Almac Group, Aspen API, Neuland Laboratories, USV, Aurigene Pharmaceutical Services, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world GMP Peptide Manufacturing Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global GMP Peptide Manufacturing Services Market, By Region:
1. How big is the global GMP Peptide Manufacturing Services market?
2. What is the demand of the global GMP Peptide Manufacturing Services market?
3. What is the year over year growth of the global GMP Peptide Manufacturing Services market?
4. What is the total value of the global GMP Peptide Manufacturing Services market?
5. Who are the Major Players in the global GMP Peptide Manufacturing Services market?
6. What are the growth factors driving the market demand?
GMP Peptide Manufacturing Services refer to manufacturing services for therapeutic peptide active pharmaceutical ingredients under GMP-compliant conditions, covering process confirmation, scale-up production, validation batches, registration batches, and commercial supply, with a strong focus on product quality, batch consistency, traceability, and regulatory compliance. This segment is typically based on solid-phase peptide synthesis, liquid-phase fragment coupling, and subsequent purification, lyophilization, and packaging operations. Its upstream supply chain mainly includes protected amino acids, specialty amino acids, resin supports, coupling reagents, cleavage and deprotection reagents, organic solvents, purification media, analytical consumables, and GMP packaging materials, while the main downstream customers are innovative pharmaceutical companies, biotechnology firms, specialty generic drug developers, and drug manufacturers that further formulate peptide APIs into injectables, lyophilized products, or other dosage forms. This type of service requires a high standard of manufacturing control, batch-to-batch consistency, impurity profile management, documentation systems, and reliable long-term supply. The global gross margin of GMP Peptide Manufacturing Services in 2025 is estimated at 25%-40%.
The GMP peptide manufacturing services market is undergoing a structural upgrade, supported by rapid demand expansion and rising technical requirements. Historically, peptide manufacturing was mainly driven by traditional short peptides, generic peptide APIs, and small clinical-stage projects, with competition centered on synthesis experience, quality systems, purification capability, and regulatory support. In recent years, GLP-1 therapeutics, long-acting modified peptides, complex cyclic peptides, constrained peptides, peptide conjugates, and personalized peptide vaccines have significantly increased demand for GMP-grade synthesis, scale-up, purification, lyophilization, and analytical development. Leading CDMOs benefit from commercial project experience, global pharmaceutical customer relationships, and multi-regional capacity layouts, while suppliers in China, India, and Japan are accelerating their participation through GMP capacity expansion, TIDES platform development, and stronger local supply chains. Future growth will be primarily driven by the expansion of innovative peptide pipelines and the commercialization of high-volume peptide drugs. Applications in metabolic diseases, oncology and immunotherapy, rare diseases, infectious diseases, and peptide conjugate therapies continue to encourage pharmaceutical companies to outsource peptide API development and manufacturing to specialized service providers. Compared with small-molecule APIs, peptide manufacturing involves higher complexity in sequence design, protecting group strategy, impurity profiling, yield optimization, and batch-to-batch consistency. Building in-house peptide manufacturing capacity requires substantial capital investment and deep process expertise, which supports a continued increase in outsourcing penetration. At the same time, pharmaceutical customers are placing greater emphasis on supply security and regulatory compliance, pushing peptide CDMOs to evolve from standalone synthesis providers into integrated partners covering process development, analytical methods, registration batches, validation batches, and commercial supply. From a technology perspective, solid-phase peptide synthesis remains the mainstream route for complex and long-chain peptides, while liquid-phase synthesis and hybrid solid-liquid strategies remain valuable for selected short peptides, large-volume commercial products, and cost-sensitive programs. As project scale increases, preparative chromatography, continuous purification, solvent recovery, green chemistry, automated synthesis, lyophilization efficiency, and high-purity impurity control will become key areas of differentiation. Service providers with capabilities in complex modification, lipidation, cyclization, fragment condensation, incorporation of non-natural amino acids, and peptide-drug conjugation will be better positioned to participate in high-value innovative drug programs. Future competition will not be defined by capacity alone, but by the combined strength of process platforms, quality systems, cost control, and global delivery capabilities. The industry still faces several constraints. Peptide manufacturing relies heavily on resins, protected amino acids, coupling reagents, high-purity solvents, and preparative purification equipment. Volatility in raw material prices, stricter environmental requirements, and rising solvent treatment costs may pressure margins for some suppliers. Rapid commercialization of large-volume peptide drugs may create temporary capacity shortages, but concentrated capacity expansion by multiple companies could also lead to price competition in less complex product segments. In parallel, global pharmaceutical regulators continue to raise expectations for impurity control, residual solvents, data integrity, and supply chain traceability, creating higher barriers for smaller manufacturers in audits, validation, and international regulatory documentation. Overall, GMP peptide manufacturing services remain a high-growth market, but industry polarization is likely to become more pronounced, with platform-based leaders and specialized technology-driven manufacturers gaining more stable long-term opportunities.
This report studies the global GMP Peptide Manufacturing Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for GMP Peptide Manufacturing Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GMP Peptide Manufacturing Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GMP Peptide Manufacturing Services total market, 2021-2032, (USD Million)
Global GMP Peptide Manufacturing Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: GMP Peptide Manufacturing Services total market, key domestic companies, and share, (USD Million)
Global GMP Peptide Manufacturing Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global GMP Peptide Manufacturing Services total market by Type, CAGR, 2021-2032, (USD Million)
Global GMP Peptide Manufacturing Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global GMP Peptide Manufacturing Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PolyPeptide, Bachem, AmbioPharm, CordenPharma, Piramal Pharma Solutions, Almac Group, Aspen API, Neuland Laboratories, USV, Aurigene Pharmaceutical Services, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world GMP Peptide Manufacturing Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global GMP Peptide Manufacturing Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Process Development
- Clinical GMP Manufacturing
- Commercial GMP Manufacturing
- Other
- SPPS
- LPPS
- Hybrid Technology
- Metabolic Diseases
- Oncology
- Endocrine and Reproductive Health
- Rare Diseases and Specialty Care
- Others
- Pharmaceutical Companies
- Biotechnology Companies
- Academic and Research Institutions
- Others
- PolyPeptide
- Bachem
- AmbioPharm
- CordenPharma
- Piramal Pharma Solutions
- Almac Group
- Aspen API
- Neuland Laboratories
- USV
- Aurigene Pharmaceutical Services
- PeptiStar
- BCN Peptides
- Cambrex
- Nippon Shokubai
- ScinoPharm
- Chengdu Shengnuo Biopharm
- WuXi TIDES
- Asymchem
- Medtide
- Jiuzhou Pharma
- Hybio Pharmaceutical
- JYMed Peptide
1. How big is the global GMP Peptide Manufacturing Services market?
2. What is the demand of the global GMP Peptide Manufacturing Services market?
3. What is the year over year growth of the global GMP Peptide Manufacturing Services market?
4. What is the total value of the global GMP Peptide Manufacturing Services market?
5. Who are the Major Players in the global GMP Peptide Manufacturing Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 GMP Peptide Manufacturing Services Introduction
1.2 World GMP Peptide Manufacturing Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World GMP Peptide Manufacturing Services Total Market by Region (by Headquarter Location)
1.3.1 World GMP Peptide Manufacturing Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.3 China Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.4 Europe Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.5 Japan Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.6 South Korea Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.7 ASEAN Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.8 India Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 GMP Peptide Manufacturing Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.2 World GMP Peptide Manufacturing Services Consumption Value by Region
2.2.1 World GMP Peptide Manufacturing Services Consumption Value by Region (2021-2026)
2.2.2 World GMP Peptide Manufacturing Services Consumption Value Forecast by Region (2027-2032)
2.3 United States GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.4 China GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.5 Europe GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.6 Japan GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.7 South Korea GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.8 ASEAN GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.9 India GMP Peptide Manufacturing Services Consumption Value (2021-2032)
3 WORLD GMP PEPTIDE MANUFACTURING SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World GMP Peptide Manufacturing Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global GMP Peptide Manufacturing Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for GMP Peptide Manufacturing Services in 2025
3.2.3 Global Concentration Ratios (CR8) for GMP Peptide Manufacturing Services in 2025
3.3 GMP Peptide Manufacturing Services Company Evaluation Quadrant
3.4 GMP Peptide Manufacturing Services Market: Overall Company Footprint Analysis
3.4.1 GMP Peptide Manufacturing Services Market: Region Footprint
3.4.2 GMP Peptide Manufacturing Services Market: Company Product Type Footprint
3.4.3 GMP Peptide Manufacturing Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: GMP Peptide Manufacturing Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: GMP Peptide Manufacturing Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: GMP Peptide Manufacturing Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: GMP Peptide Manufacturing Services Consumption Value Comparison
4.2.1 United States VS China: GMP Peptide Manufacturing Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: GMP Peptide Manufacturing Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based GMP Peptide Manufacturing Services Companies and Market Share, 2021-2026
4.3.1 United States Based GMP Peptide Manufacturing Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies GMP Peptide Manufacturing Services Revenue, (2021-2026)
4.4 China Based Companies GMP Peptide Manufacturing Services Revenue and Market Share, 2021-2026
4.4.1 China Based GMP Peptide Manufacturing Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies GMP Peptide Manufacturing Services Revenue, (2021-2026)
4.5 Rest of World Based GMP Peptide Manufacturing Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based GMP Peptide Manufacturing Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies GMP Peptide Manufacturing Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World GMP Peptide Manufacturing Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Process Development
5.2.2 Clinical GMP Manufacturing
5.2.3 Commercial GMP Manufacturing
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World GMP Peptide Manufacturing Services Market Size by Type (2021-2026)
5.3.2 World GMP Peptide Manufacturing Services Market Size by Type (2027-2032)
5.3.3 World GMP Peptide Manufacturing Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SYNTHESIS TECHNOLOGY
6.1 World GMP Peptide Manufacturing Services Market Size Overview by Synthesis Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Synthesis Technology
6.2.1 SPPS
6.2.2 LPPS
6.2.3 Hybrid Technology
6.3 Market Segment by Synthesis Technology
6.3.1 World GMP Peptide Manufacturing Services Market Size by Synthesis Technology (2021-2026)
6.3.2 World GMP Peptide Manufacturing Services Market Size by Synthesis Technology (2027-2032)
6.3.3 World GMP Peptide Manufacturing Services Market Size Market Share by Synthesis Technology (2027-2032)
7 MARKET ANALYSIS BY THERAPEUTIC AREA
7.1 World GMP Peptide Manufacturing Services Market Size Overview by Therapeutic Area: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Therapeutic Area
7.2.1 Metabolic Diseases
7.2.2 Oncology
7.2.3 Endocrine and Reproductive Health
7.2.4 Rare Diseases and Specialty Care
7.2.5 Others
7.3 Market Segment by Therapeutic Area
7.3.1 World GMP Peptide Manufacturing Services Market Size by Therapeutic Area (2021-2026)
7.3.2 World GMP Peptide Manufacturing Services Market Size by Therapeutic Area (2027-2032)
7.3.3 World GMP Peptide Manufacturing Services Market Size Market Share by Therapeutic Area (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World GMP Peptide Manufacturing Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical Companies
8.2.2 Biotechnology Companies
8.2.3 Academic and Research Institutions
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World GMP Peptide Manufacturing Services Market Size by Application (2021-2026)
8.3.2 World GMP Peptide Manufacturing Services Market Size by Application (2027-2032)
8.3.3 World GMP Peptide Manufacturing Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 PolyPeptide
9.1.1 PolyPeptide Details
9.1.2 PolyPeptide Major Business
9.1.3 PolyPeptide GMP Peptide Manufacturing Services Product and Services
9.1.4 PolyPeptide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 PolyPeptide Recent Developments/Updates
9.1.6 PolyPeptide Competitive Strengths & Weaknesses
9.2 Bachem
9.2.1 Bachem Details
9.2.2 Bachem Major Business
9.2.3 Bachem GMP Peptide Manufacturing Services Product and Services
9.2.4 Bachem GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Bachem Recent Developments/Updates
9.2.6 Bachem Competitive Strengths & Weaknesses
9.3 AmbioPharm
9.3.1 AmbioPharm Details
9.3.2 AmbioPharm Major Business
9.3.3 AmbioPharm GMP Peptide Manufacturing Services Product and Services
9.3.4 AmbioPharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 AmbioPharm Recent Developments/Updates
9.3.6 AmbioPharm Competitive Strengths & Weaknesses
9.4 CordenPharma
9.4.1 CordenPharma Details
9.4.2 CordenPharma Major Business
9.4.3 CordenPharma GMP Peptide Manufacturing Services Product and Services
9.4.4 CordenPharma GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 CordenPharma Recent Developments/Updates
9.4.6 CordenPharma Competitive Strengths & Weaknesses
9.5 Piramal Pharma Solutions
9.5.1 Piramal Pharma Solutions Details
9.5.2 Piramal Pharma Solutions Major Business
9.5.3 Piramal Pharma Solutions GMP Peptide Manufacturing Services Product and Services
9.5.4 Piramal Pharma Solutions GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Piramal Pharma Solutions Recent Developments/Updates
9.5.6 Piramal Pharma Solutions Competitive Strengths & Weaknesses
9.6 Almac Group
9.6.1 Almac Group Details
9.6.2 Almac Group Major Business
9.6.3 Almac Group GMP Peptide Manufacturing Services Product and Services
9.6.4 Almac Group GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Almac Group Recent Developments/Updates
9.6.6 Almac Group Competitive Strengths & Weaknesses
9.7 Aspen API
9.7.1 Aspen API Details
9.7.2 Aspen API Major Business
9.7.3 Aspen API GMP Peptide Manufacturing Services Product and Services
9.7.4 Aspen API GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Aspen API Recent Developments/Updates
9.7.6 Aspen API Competitive Strengths & Weaknesses
9.8 Neuland Laboratories
9.8.1 Neuland Laboratories Details
9.8.2 Neuland Laboratories Major Business
9.8.3 Neuland Laboratories GMP Peptide Manufacturing Services Product and Services
9.8.4 Neuland Laboratories GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Neuland Laboratories Recent Developments/Updates
9.8.6 Neuland Laboratories Competitive Strengths & Weaknesses
9.9 USV
9.9.1 USV Details
9.9.2 USV Major Business
9.9.3 USV GMP Peptide Manufacturing Services Product and Services
9.9.4 USV GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 USV Recent Developments/Updates
9.9.6 USV Competitive Strengths & Weaknesses
9.10 Aurigene Pharmaceutical Services
9.10.1 Aurigene Pharmaceutical Services Details
9.10.2 Aurigene Pharmaceutical Services Major Business
9.10.3 Aurigene Pharmaceutical Services GMP Peptide Manufacturing Services Product and Services
9.10.4 Aurigene Pharmaceutical Services GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Aurigene Pharmaceutical Services Recent Developments/Updates
9.10.6 Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
9.11 PeptiStar
9.11.1 PeptiStar Details
9.11.2 PeptiStar Major Business
9.11.3 PeptiStar GMP Peptide Manufacturing Services Product and Services
9.11.4 PeptiStar GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 PeptiStar Recent Developments/Updates
9.11.6 PeptiStar Competitive Strengths & Weaknesses
9.12 BCN Peptides
9.12.1 BCN Peptides Details
9.12.2 BCN Peptides Major Business
9.12.3 BCN Peptides GMP Peptide Manufacturing Services Product and Services
9.12.4 BCN Peptides GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 BCN Peptides Recent Developments/Updates
9.12.6 BCN Peptides Competitive Strengths & Weaknesses
9.13 Cambrex
9.13.1 Cambrex Details
9.13.2 Cambrex Major Business
9.13.3 Cambrex GMP Peptide Manufacturing Services Product and Services
9.13.4 Cambrex GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Cambrex Recent Developments/Updates
9.13.6 Cambrex Competitive Strengths & Weaknesses
9.14 Nippon Shokubai
9.14.1 Nippon Shokubai Details
9.14.2 Nippon Shokubai Major Business
9.14.3 Nippon Shokubai GMP Peptide Manufacturing Services Product and Services
9.14.4 Nippon Shokubai GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Nippon Shokubai Recent Developments/Updates
9.14.6 Nippon Shokubai Competitive Strengths & Weaknesses
9.15 ScinoPharm
9.15.1 ScinoPharm Details
9.15.2 ScinoPharm Major Business
9.15.3 ScinoPharm GMP Peptide Manufacturing Services Product and Services
9.15.4 ScinoPharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 ScinoPharm Recent Developments/Updates
9.15.6 ScinoPharm Competitive Strengths & Weaknesses
9.16 Chengdu Shengnuo Biopharm
9.16.1 Chengdu Shengnuo Biopharm Details
9.16.2 Chengdu Shengnuo Biopharm Major Business
9.16.3 Chengdu Shengnuo Biopharm GMP Peptide Manufacturing Services Product and Services
9.16.4 Chengdu Shengnuo Biopharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Chengdu Shengnuo Biopharm Recent Developments/Updates
9.16.6 Chengdu Shengnuo Biopharm Competitive Strengths & Weaknesses
9.17 WuXi TIDES
9.17.1 WuXi TIDES Details
9.17.2 WuXi TIDES Major Business
9.17.3 WuXi TIDES GMP Peptide Manufacturing Services Product and Services
9.17.4 WuXi TIDES GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 WuXi TIDES Recent Developments/Updates
9.17.6 WuXi TIDES Competitive Strengths & Weaknesses
9.18 Asymchem
9.18.1 Asymchem Details
9.18.2 Asymchem Major Business
9.18.3 Asymchem GMP Peptide Manufacturing Services Product and Services
9.18.4 Asymchem GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Asymchem Recent Developments/Updates
9.18.6 Asymchem Competitive Strengths & Weaknesses
9.19 Medtide
9.19.1 Medtide Details
9.19.2 Medtide Major Business
9.19.3 Medtide GMP Peptide Manufacturing Services Product and Services
9.19.4 Medtide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Medtide Recent Developments/Updates
9.19.6 Medtide Competitive Strengths & Weaknesses
9.20 Jiuzhou Pharma
9.20.1 Jiuzhou Pharma Details
9.20.2 Jiuzhou Pharma Major Business
9.20.3 Jiuzhou Pharma GMP Peptide Manufacturing Services Product and Services
9.20.4 Jiuzhou Pharma GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Jiuzhou Pharma Recent Developments/Updates
9.20.6 Jiuzhou Pharma Competitive Strengths & Weaknesses
9.21 Hybio Pharmaceutical
9.21.1 Hybio Pharmaceutical Details
9.21.2 Hybio Pharmaceutical Major Business
9.21.3 Hybio Pharmaceutical GMP Peptide Manufacturing Services Product and Services
9.21.4 Hybio Pharmaceutical GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Hybio Pharmaceutical Recent Developments/Updates
9.21.6 Hybio Pharmaceutical Competitive Strengths & Weaknesses
9.22 JYMed Peptide
9.22.1 JYMed Peptide Details
9.22.2 JYMed Peptide Major Business
9.22.3 JYMed Peptide GMP Peptide Manufacturing Services Product and Services
9.22.4 JYMed Peptide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 JYMed Peptide Recent Developments/Updates
9.22.6 JYMed Peptide Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 GMP Peptide Manufacturing Services Industry Chain
10.2 GMP Peptide Manufacturing Services Upstream Analysis
10.3 GMP Peptide Manufacturing Services Midstream Analysis
10.4 GMP Peptide Manufacturing Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 GMP Peptide Manufacturing Services Introduction
1.2 World GMP Peptide Manufacturing Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World GMP Peptide Manufacturing Services Total Market by Region (by Headquarter Location)
1.3.1 World GMP Peptide Manufacturing Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.3 China Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.4 Europe Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.5 Japan Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.6 South Korea Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.7 ASEAN Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.3.8 India Based Company GMP Peptide Manufacturing Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 GMP Peptide Manufacturing Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.2 World GMP Peptide Manufacturing Services Consumption Value by Region
2.2.1 World GMP Peptide Manufacturing Services Consumption Value by Region (2021-2026)
2.2.2 World GMP Peptide Manufacturing Services Consumption Value Forecast by Region (2027-2032)
2.3 United States GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.4 China GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.5 Europe GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.6 Japan GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.7 South Korea GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.8 ASEAN GMP Peptide Manufacturing Services Consumption Value (2021-2032)
2.9 India GMP Peptide Manufacturing Services Consumption Value (2021-2032)
3 WORLD GMP PEPTIDE MANUFACTURING SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World GMP Peptide Manufacturing Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global GMP Peptide Manufacturing Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for GMP Peptide Manufacturing Services in 2025
3.2.3 Global Concentration Ratios (CR8) for GMP Peptide Manufacturing Services in 2025
3.3 GMP Peptide Manufacturing Services Company Evaluation Quadrant
3.4 GMP Peptide Manufacturing Services Market: Overall Company Footprint Analysis
3.4.1 GMP Peptide Manufacturing Services Market: Region Footprint
3.4.2 GMP Peptide Manufacturing Services Market: Company Product Type Footprint
3.4.3 GMP Peptide Manufacturing Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: GMP Peptide Manufacturing Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: GMP Peptide Manufacturing Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: GMP Peptide Manufacturing Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: GMP Peptide Manufacturing Services Consumption Value Comparison
4.2.1 United States VS China: GMP Peptide Manufacturing Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: GMP Peptide Manufacturing Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based GMP Peptide Manufacturing Services Companies and Market Share, 2021-2026
4.3.1 United States Based GMP Peptide Manufacturing Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies GMP Peptide Manufacturing Services Revenue, (2021-2026)
4.4 China Based Companies GMP Peptide Manufacturing Services Revenue and Market Share, 2021-2026
4.4.1 China Based GMP Peptide Manufacturing Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies GMP Peptide Manufacturing Services Revenue, (2021-2026)
4.5 Rest of World Based GMP Peptide Manufacturing Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based GMP Peptide Manufacturing Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies GMP Peptide Manufacturing Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World GMP Peptide Manufacturing Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Process Development
5.2.2 Clinical GMP Manufacturing
5.2.3 Commercial GMP Manufacturing
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World GMP Peptide Manufacturing Services Market Size by Type (2021-2026)
5.3.2 World GMP Peptide Manufacturing Services Market Size by Type (2027-2032)
5.3.3 World GMP Peptide Manufacturing Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SYNTHESIS TECHNOLOGY
6.1 World GMP Peptide Manufacturing Services Market Size Overview by Synthesis Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Synthesis Technology
6.2.1 SPPS
6.2.2 LPPS
6.2.3 Hybrid Technology
6.3 Market Segment by Synthesis Technology
6.3.1 World GMP Peptide Manufacturing Services Market Size by Synthesis Technology (2021-2026)
6.3.2 World GMP Peptide Manufacturing Services Market Size by Synthesis Technology (2027-2032)
6.3.3 World GMP Peptide Manufacturing Services Market Size Market Share by Synthesis Technology (2027-2032)
7 MARKET ANALYSIS BY THERAPEUTIC AREA
7.1 World GMP Peptide Manufacturing Services Market Size Overview by Therapeutic Area: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Therapeutic Area
7.2.1 Metabolic Diseases
7.2.2 Oncology
7.2.3 Endocrine and Reproductive Health
7.2.4 Rare Diseases and Specialty Care
7.2.5 Others
7.3 Market Segment by Therapeutic Area
7.3.1 World GMP Peptide Manufacturing Services Market Size by Therapeutic Area (2021-2026)
7.3.2 World GMP Peptide Manufacturing Services Market Size by Therapeutic Area (2027-2032)
7.3.3 World GMP Peptide Manufacturing Services Market Size Market Share by Therapeutic Area (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World GMP Peptide Manufacturing Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical Companies
8.2.2 Biotechnology Companies
8.2.3 Academic and Research Institutions
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World GMP Peptide Manufacturing Services Market Size by Application (2021-2026)
8.3.2 World GMP Peptide Manufacturing Services Market Size by Application (2027-2032)
8.3.3 World GMP Peptide Manufacturing Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 PolyPeptide
9.1.1 PolyPeptide Details
9.1.2 PolyPeptide Major Business
9.1.3 PolyPeptide GMP Peptide Manufacturing Services Product and Services
9.1.4 PolyPeptide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 PolyPeptide Recent Developments/Updates
9.1.6 PolyPeptide Competitive Strengths & Weaknesses
9.2 Bachem
9.2.1 Bachem Details
9.2.2 Bachem Major Business
9.2.3 Bachem GMP Peptide Manufacturing Services Product and Services
9.2.4 Bachem GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Bachem Recent Developments/Updates
9.2.6 Bachem Competitive Strengths & Weaknesses
9.3 AmbioPharm
9.3.1 AmbioPharm Details
9.3.2 AmbioPharm Major Business
9.3.3 AmbioPharm GMP Peptide Manufacturing Services Product and Services
9.3.4 AmbioPharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 AmbioPharm Recent Developments/Updates
9.3.6 AmbioPharm Competitive Strengths & Weaknesses
9.4 CordenPharma
9.4.1 CordenPharma Details
9.4.2 CordenPharma Major Business
9.4.3 CordenPharma GMP Peptide Manufacturing Services Product and Services
9.4.4 CordenPharma GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 CordenPharma Recent Developments/Updates
9.4.6 CordenPharma Competitive Strengths & Weaknesses
9.5 Piramal Pharma Solutions
9.5.1 Piramal Pharma Solutions Details
9.5.2 Piramal Pharma Solutions Major Business
9.5.3 Piramal Pharma Solutions GMP Peptide Manufacturing Services Product and Services
9.5.4 Piramal Pharma Solutions GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Piramal Pharma Solutions Recent Developments/Updates
9.5.6 Piramal Pharma Solutions Competitive Strengths & Weaknesses
9.6 Almac Group
9.6.1 Almac Group Details
9.6.2 Almac Group Major Business
9.6.3 Almac Group GMP Peptide Manufacturing Services Product and Services
9.6.4 Almac Group GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Almac Group Recent Developments/Updates
9.6.6 Almac Group Competitive Strengths & Weaknesses
9.7 Aspen API
9.7.1 Aspen API Details
9.7.2 Aspen API Major Business
9.7.3 Aspen API GMP Peptide Manufacturing Services Product and Services
9.7.4 Aspen API GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Aspen API Recent Developments/Updates
9.7.6 Aspen API Competitive Strengths & Weaknesses
9.8 Neuland Laboratories
9.8.1 Neuland Laboratories Details
9.8.2 Neuland Laboratories Major Business
9.8.3 Neuland Laboratories GMP Peptide Manufacturing Services Product and Services
9.8.4 Neuland Laboratories GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Neuland Laboratories Recent Developments/Updates
9.8.6 Neuland Laboratories Competitive Strengths & Weaknesses
9.9 USV
9.9.1 USV Details
9.9.2 USV Major Business
9.9.3 USV GMP Peptide Manufacturing Services Product and Services
9.9.4 USV GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 USV Recent Developments/Updates
9.9.6 USV Competitive Strengths & Weaknesses
9.10 Aurigene Pharmaceutical Services
9.10.1 Aurigene Pharmaceutical Services Details
9.10.2 Aurigene Pharmaceutical Services Major Business
9.10.3 Aurigene Pharmaceutical Services GMP Peptide Manufacturing Services Product and Services
9.10.4 Aurigene Pharmaceutical Services GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Aurigene Pharmaceutical Services Recent Developments/Updates
9.10.6 Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
9.11 PeptiStar
9.11.1 PeptiStar Details
9.11.2 PeptiStar Major Business
9.11.3 PeptiStar GMP Peptide Manufacturing Services Product and Services
9.11.4 PeptiStar GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 PeptiStar Recent Developments/Updates
9.11.6 PeptiStar Competitive Strengths & Weaknesses
9.12 BCN Peptides
9.12.1 BCN Peptides Details
9.12.2 BCN Peptides Major Business
9.12.3 BCN Peptides GMP Peptide Manufacturing Services Product and Services
9.12.4 BCN Peptides GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 BCN Peptides Recent Developments/Updates
9.12.6 BCN Peptides Competitive Strengths & Weaknesses
9.13 Cambrex
9.13.1 Cambrex Details
9.13.2 Cambrex Major Business
9.13.3 Cambrex GMP Peptide Manufacturing Services Product and Services
9.13.4 Cambrex GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Cambrex Recent Developments/Updates
9.13.6 Cambrex Competitive Strengths & Weaknesses
9.14 Nippon Shokubai
9.14.1 Nippon Shokubai Details
9.14.2 Nippon Shokubai Major Business
9.14.3 Nippon Shokubai GMP Peptide Manufacturing Services Product and Services
9.14.4 Nippon Shokubai GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Nippon Shokubai Recent Developments/Updates
9.14.6 Nippon Shokubai Competitive Strengths & Weaknesses
9.15 ScinoPharm
9.15.1 ScinoPharm Details
9.15.2 ScinoPharm Major Business
9.15.3 ScinoPharm GMP Peptide Manufacturing Services Product and Services
9.15.4 ScinoPharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 ScinoPharm Recent Developments/Updates
9.15.6 ScinoPharm Competitive Strengths & Weaknesses
9.16 Chengdu Shengnuo Biopharm
9.16.1 Chengdu Shengnuo Biopharm Details
9.16.2 Chengdu Shengnuo Biopharm Major Business
9.16.3 Chengdu Shengnuo Biopharm GMP Peptide Manufacturing Services Product and Services
9.16.4 Chengdu Shengnuo Biopharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Chengdu Shengnuo Biopharm Recent Developments/Updates
9.16.6 Chengdu Shengnuo Biopharm Competitive Strengths & Weaknesses
9.17 WuXi TIDES
9.17.1 WuXi TIDES Details
9.17.2 WuXi TIDES Major Business
9.17.3 WuXi TIDES GMP Peptide Manufacturing Services Product and Services
9.17.4 WuXi TIDES GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 WuXi TIDES Recent Developments/Updates
9.17.6 WuXi TIDES Competitive Strengths & Weaknesses
9.18 Asymchem
9.18.1 Asymchem Details
9.18.2 Asymchem Major Business
9.18.3 Asymchem GMP Peptide Manufacturing Services Product and Services
9.18.4 Asymchem GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Asymchem Recent Developments/Updates
9.18.6 Asymchem Competitive Strengths & Weaknesses
9.19 Medtide
9.19.1 Medtide Details
9.19.2 Medtide Major Business
9.19.3 Medtide GMP Peptide Manufacturing Services Product and Services
9.19.4 Medtide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Medtide Recent Developments/Updates
9.19.6 Medtide Competitive Strengths & Weaknesses
9.20 Jiuzhou Pharma
9.20.1 Jiuzhou Pharma Details
9.20.2 Jiuzhou Pharma Major Business
9.20.3 Jiuzhou Pharma GMP Peptide Manufacturing Services Product and Services
9.20.4 Jiuzhou Pharma GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Jiuzhou Pharma Recent Developments/Updates
9.20.6 Jiuzhou Pharma Competitive Strengths & Weaknesses
9.21 Hybio Pharmaceutical
9.21.1 Hybio Pharmaceutical Details
9.21.2 Hybio Pharmaceutical Major Business
9.21.3 Hybio Pharmaceutical GMP Peptide Manufacturing Services Product and Services
9.21.4 Hybio Pharmaceutical GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Hybio Pharmaceutical Recent Developments/Updates
9.21.6 Hybio Pharmaceutical Competitive Strengths & Weaknesses
9.22 JYMed Peptide
9.22.1 JYMed Peptide Details
9.22.2 JYMed Peptide Major Business
9.22.3 JYMed Peptide GMP Peptide Manufacturing Services Product and Services
9.22.4 JYMed Peptide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 JYMed Peptide Recent Developments/Updates
9.22.6 JYMed Peptide Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 GMP Peptide Manufacturing Services Industry Chain
10.2 GMP Peptide Manufacturing Services Upstream Analysis
10.3 GMP Peptide Manufacturing Services Midstream Analysis
10.4 GMP Peptide Manufacturing Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World GMP Peptide Manufacturing Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World GMP Peptide Manufacturing Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World GMP Peptide Manufacturing Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World GMP Peptide Manufacturing Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World GMP Peptide Manufacturing Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World GMP Peptide Manufacturing Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World GMP Peptide Manufacturing Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World GMP Peptide Manufacturing Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World GMP Peptide Manufacturing Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key GMP Peptide Manufacturing Services Players in 2025
Table 12. World GMP Peptide Manufacturing Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global GMP Peptide Manufacturing Services Company Evaluation Quadrant
Table 14. Head Office of Key GMP Peptide Manufacturing Services Players
Table 15. GMP Peptide Manufacturing Services Market: Company Product Type Footprint
Table 16. GMP Peptide Manufacturing Services Market: Company Product Application Footprint
Table 17. GMP Peptide Manufacturing Services Mergers & Acquisitions Activity
Table 18. United States VS China GMP Peptide Manufacturing Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China GMP Peptide Manufacturing Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based GMP Peptide Manufacturing Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies GMP Peptide Manufacturing Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies GMP Peptide Manufacturing Services Revenue Market Share (2021-2026)
Table 23. China Based GMP Peptide Manufacturing Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies GMP Peptide Manufacturing Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies GMP Peptide Manufacturing Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based GMP Peptide Manufacturing Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies GMP Peptide Manufacturing Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies GMP Peptide Manufacturing Services Revenue Market Share (2021-2026)
Table 29. World GMP Peptide Manufacturing Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World GMP Peptide Manufacturing Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World GMP Peptide Manufacturing Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World GMP Peptide Manufacturing Services Market Size by Synthesis Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World GMP Peptide Manufacturing Services Market Size Value by Synthesis Technology (2021-2026) & (USD Million)
Table 34. World GMP Peptide Manufacturing Services Market Size by Synthesis Technology (2027-2032) & (USD Million)
Table 35. World GMP Peptide Manufacturing Services Market Size by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Table 36. World GMP Peptide Manufacturing Services Market Size Value by Therapeutic Area (2021-2026) & (USD Million)
Table 37. World GMP Peptide Manufacturing Services Market Size by Therapeutic Area (2027-2032) & (USD Million)
Table 38. World GMP Peptide Manufacturing Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World GMP Peptide Manufacturing Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World GMP Peptide Manufacturing Services Market Size by Application (2027-2032) & (USD Million)
Table 41. PolyPeptide Basic Information, Manufacturing Base and Competitors
Table 42. PolyPeptide Major Business
Table 43. PolyPeptide GMP Peptide Manufacturing Services Product and Services
Table 44. PolyPeptide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. PolyPeptide Recent Developments/Updates
Table 46. PolyPeptide Competitive Strengths & Weaknesses
Table 47. Bachem Basic Information, Manufacturing Base and Competitors
Table 48. Bachem Major Business
Table 49. Bachem GMP Peptide Manufacturing Services Product and Services
Table 50. Bachem GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Bachem Recent Developments/Updates
Table 52. Bachem Competitive Strengths & Weaknesses
Table 53. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 54. AmbioPharm Major Business
Table 55. AmbioPharm GMP Peptide Manufacturing Services Product and Services
Table 56. AmbioPharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. AmbioPharm Recent Developments/Updates
Table 58. AmbioPharm Competitive Strengths & Weaknesses
Table 59. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 60. CordenPharma Major Business
Table 61. CordenPharma GMP Peptide Manufacturing Services Product and Services
Table 62. CordenPharma GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. CordenPharma Recent Developments/Updates
Table 64. CordenPharma Competitive Strengths & Weaknesses
Table 65. Piramal Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 66. Piramal Pharma Solutions Major Business
Table 67. Piramal Pharma Solutions GMP Peptide Manufacturing Services Product and Services
Table 68. Piramal Pharma Solutions GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Piramal Pharma Solutions Recent Developments/Updates
Table 70. Piramal Pharma Solutions Competitive Strengths & Weaknesses
Table 71. Almac Group Basic Information, Manufacturing Base and Competitors
Table 72. Almac Group Major Business
Table 73. Almac Group GMP Peptide Manufacturing Services Product and Services
Table 74. Almac Group GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Almac Group Recent Developments/Updates
Table 76. Almac Group Competitive Strengths & Weaknesses
Table 77. Aspen API Basic Information, Manufacturing Base and Competitors
Table 78. Aspen API Major Business
Table 79. Aspen API GMP Peptide Manufacturing Services Product and Services
Table 80. Aspen API GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Aspen API Recent Developments/Updates
Table 82. Aspen API Competitive Strengths & Weaknesses
Table 83. Neuland Laboratories Basic Information, Manufacturing Base and Competitors
Table 84. Neuland Laboratories Major Business
Table 85. Neuland Laboratories GMP Peptide Manufacturing Services Product and Services
Table 86. Neuland Laboratories GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Neuland Laboratories Recent Developments/Updates
Table 88. Neuland Laboratories Competitive Strengths & Weaknesses
Table 89. USV Basic Information, Manufacturing Base and Competitors
Table 90. USV Major Business
Table 91. USV GMP Peptide Manufacturing Services Product and Services
Table 92. USV GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. USV Recent Developments/Updates
Table 94. USV Competitive Strengths & Weaknesses
Table 95. Aurigene Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 96. Aurigene Pharmaceutical Services Major Business
Table 97. Aurigene Pharmaceutical Services GMP Peptide Manufacturing Services Product and Services
Table 98. Aurigene Pharmaceutical Services GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Aurigene Pharmaceutical Services Recent Developments/Updates
Table 100. Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
Table 101. PeptiStar Basic Information, Manufacturing Base and Competitors
Table 102. PeptiStar Major Business
Table 103. PeptiStar GMP Peptide Manufacturing Services Product and Services
Table 104. PeptiStar GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. PeptiStar Recent Developments/Updates
Table 106. PeptiStar Competitive Strengths & Weaknesses
Table 107. BCN Peptides Basic Information, Manufacturing Base and Competitors
Table 108. BCN Peptides Major Business
Table 109. BCN Peptides GMP Peptide Manufacturing Services Product and Services
Table 110. BCN Peptides GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. BCN Peptides Recent Developments/Updates
Table 112. BCN Peptides Competitive Strengths & Weaknesses
Table 113. Cambrex Basic Information, Manufacturing Base and Competitors
Table 114. Cambrex Major Business
Table 115. Cambrex GMP Peptide Manufacturing Services Product and Services
Table 116. Cambrex GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Cambrex Recent Developments/Updates
Table 118. Cambrex Competitive Strengths & Weaknesses
Table 119. Nippon Shokubai Basic Information, Manufacturing Base and Competitors
Table 120. Nippon Shokubai Major Business
Table 121. Nippon Shokubai GMP Peptide Manufacturing Services Product and Services
Table 122. Nippon Shokubai GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Nippon Shokubai Recent Developments/Updates
Table 124. Nippon Shokubai Competitive Strengths & Weaknesses
Table 125. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 126. ScinoPharm Major Business
Table 127. ScinoPharm GMP Peptide Manufacturing Services Product and Services
Table 128. ScinoPharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. ScinoPharm Recent Developments/Updates
Table 130. ScinoPharm Competitive Strengths & Weaknesses
Table 131. Chengdu Shengnuo Biopharm Basic Information, Manufacturing Base and Competitors
Table 132. Chengdu Shengnuo Biopharm Major Business
Table 133. Chengdu Shengnuo Biopharm GMP Peptide Manufacturing Services Product and Services
Table 134. Chengdu Shengnuo Biopharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Chengdu Shengnuo Biopharm Recent Developments/Updates
Table 136. Chengdu Shengnuo Biopharm Competitive Strengths & Weaknesses
Table 137. WuXi TIDES Basic Information, Manufacturing Base and Competitors
Table 138. WuXi TIDES Major Business
Table 139. WuXi TIDES GMP Peptide Manufacturing Services Product and Services
Table 140. WuXi TIDES GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. WuXi TIDES Recent Developments/Updates
Table 142. WuXi TIDES Competitive Strengths & Weaknesses
Table 143. Asymchem Basic Information, Manufacturing Base and Competitors
Table 144. Asymchem Major Business
Table 145. Asymchem GMP Peptide Manufacturing Services Product and Services
Table 146. Asymchem GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Asymchem Recent Developments/Updates
Table 148. Asymchem Competitive Strengths & Weaknesses
Table 149. Medtide Basic Information, Manufacturing Base and Competitors
Table 150. Medtide Major Business
Table 151. Medtide GMP Peptide Manufacturing Services Product and Services
Table 152. Medtide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Medtide Recent Developments/Updates
Table 154. Medtide Competitive Strengths & Weaknesses
Table 155. Jiuzhou Pharma Basic Information, Manufacturing Base and Competitors
Table 156. Jiuzhou Pharma Major Business
Table 157. Jiuzhou Pharma GMP Peptide Manufacturing Services Product and Services
Table 158. Jiuzhou Pharma GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Jiuzhou Pharma Recent Developments/Updates
Table 160. Jiuzhou Pharma Competitive Strengths & Weaknesses
Table 161. Hybio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 162. Hybio Pharmaceutical Major Business
Table 163. Hybio Pharmaceutical GMP Peptide Manufacturing Services Product and Services
Table 164. Hybio Pharmaceutical GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Hybio Pharmaceutical Recent Developments/Updates
Table 166. Hybio Pharmaceutical Competitive Strengths & Weaknesses
Table 167. JYMed Peptide Basic Information, Manufacturing Base and Competitors
Table 168. JYMed Peptide Major Business
Table 169. JYMed Peptide GMP Peptide Manufacturing Services Product and Services
Table 170. JYMed Peptide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. JYMed Peptide Recent Developments/Updates
Table 172. JYMed Peptide Competitive Strengths & Weaknesses
Table 173. Global Key Players of GMP Peptide Manufacturing Services Upstream (Raw Materials)
Table 174. Global GMP Peptide Manufacturing Services Typical Customers
Table 1. World GMP Peptide Manufacturing Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World GMP Peptide Manufacturing Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World GMP Peptide Manufacturing Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World GMP Peptide Manufacturing Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World GMP Peptide Manufacturing Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World GMP Peptide Manufacturing Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World GMP Peptide Manufacturing Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World GMP Peptide Manufacturing Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World GMP Peptide Manufacturing Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key GMP Peptide Manufacturing Services Players in 2025
Table 12. World GMP Peptide Manufacturing Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global GMP Peptide Manufacturing Services Company Evaluation Quadrant
Table 14. Head Office of Key GMP Peptide Manufacturing Services Players
Table 15. GMP Peptide Manufacturing Services Market: Company Product Type Footprint
Table 16. GMP Peptide Manufacturing Services Market: Company Product Application Footprint
Table 17. GMP Peptide Manufacturing Services Mergers & Acquisitions Activity
Table 18. United States VS China GMP Peptide Manufacturing Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China GMP Peptide Manufacturing Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based GMP Peptide Manufacturing Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies GMP Peptide Manufacturing Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies GMP Peptide Manufacturing Services Revenue Market Share (2021-2026)
Table 23. China Based GMP Peptide Manufacturing Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies GMP Peptide Manufacturing Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies GMP Peptide Manufacturing Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based GMP Peptide Manufacturing Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies GMP Peptide Manufacturing Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies GMP Peptide Manufacturing Services Revenue Market Share (2021-2026)
Table 29. World GMP Peptide Manufacturing Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World GMP Peptide Manufacturing Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World GMP Peptide Manufacturing Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World GMP Peptide Manufacturing Services Market Size by Synthesis Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World GMP Peptide Manufacturing Services Market Size Value by Synthesis Technology (2021-2026) & (USD Million)
Table 34. World GMP Peptide Manufacturing Services Market Size by Synthesis Technology (2027-2032) & (USD Million)
Table 35. World GMP Peptide Manufacturing Services Market Size by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Table 36. World GMP Peptide Manufacturing Services Market Size Value by Therapeutic Area (2021-2026) & (USD Million)
Table 37. World GMP Peptide Manufacturing Services Market Size by Therapeutic Area (2027-2032) & (USD Million)
Table 38. World GMP Peptide Manufacturing Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World GMP Peptide Manufacturing Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World GMP Peptide Manufacturing Services Market Size by Application (2027-2032) & (USD Million)
Table 41. PolyPeptide Basic Information, Manufacturing Base and Competitors
Table 42. PolyPeptide Major Business
Table 43. PolyPeptide GMP Peptide Manufacturing Services Product and Services
Table 44. PolyPeptide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. PolyPeptide Recent Developments/Updates
Table 46. PolyPeptide Competitive Strengths & Weaknesses
Table 47. Bachem Basic Information, Manufacturing Base and Competitors
Table 48. Bachem Major Business
Table 49. Bachem GMP Peptide Manufacturing Services Product and Services
Table 50. Bachem GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Bachem Recent Developments/Updates
Table 52. Bachem Competitive Strengths & Weaknesses
Table 53. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 54. AmbioPharm Major Business
Table 55. AmbioPharm GMP Peptide Manufacturing Services Product and Services
Table 56. AmbioPharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. AmbioPharm Recent Developments/Updates
Table 58. AmbioPharm Competitive Strengths & Weaknesses
Table 59. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 60. CordenPharma Major Business
Table 61. CordenPharma GMP Peptide Manufacturing Services Product and Services
Table 62. CordenPharma GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. CordenPharma Recent Developments/Updates
Table 64. CordenPharma Competitive Strengths & Weaknesses
Table 65. Piramal Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 66. Piramal Pharma Solutions Major Business
Table 67. Piramal Pharma Solutions GMP Peptide Manufacturing Services Product and Services
Table 68. Piramal Pharma Solutions GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Piramal Pharma Solutions Recent Developments/Updates
Table 70. Piramal Pharma Solutions Competitive Strengths & Weaknesses
Table 71. Almac Group Basic Information, Manufacturing Base and Competitors
Table 72. Almac Group Major Business
Table 73. Almac Group GMP Peptide Manufacturing Services Product and Services
Table 74. Almac Group GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Almac Group Recent Developments/Updates
Table 76. Almac Group Competitive Strengths & Weaknesses
Table 77. Aspen API Basic Information, Manufacturing Base and Competitors
Table 78. Aspen API Major Business
Table 79. Aspen API GMP Peptide Manufacturing Services Product and Services
Table 80. Aspen API GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Aspen API Recent Developments/Updates
Table 82. Aspen API Competitive Strengths & Weaknesses
Table 83. Neuland Laboratories Basic Information, Manufacturing Base and Competitors
Table 84. Neuland Laboratories Major Business
Table 85. Neuland Laboratories GMP Peptide Manufacturing Services Product and Services
Table 86. Neuland Laboratories GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Neuland Laboratories Recent Developments/Updates
Table 88. Neuland Laboratories Competitive Strengths & Weaknesses
Table 89. USV Basic Information, Manufacturing Base and Competitors
Table 90. USV Major Business
Table 91. USV GMP Peptide Manufacturing Services Product and Services
Table 92. USV GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. USV Recent Developments/Updates
Table 94. USV Competitive Strengths & Weaknesses
Table 95. Aurigene Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 96. Aurigene Pharmaceutical Services Major Business
Table 97. Aurigene Pharmaceutical Services GMP Peptide Manufacturing Services Product and Services
Table 98. Aurigene Pharmaceutical Services GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Aurigene Pharmaceutical Services Recent Developments/Updates
Table 100. Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
Table 101. PeptiStar Basic Information, Manufacturing Base and Competitors
Table 102. PeptiStar Major Business
Table 103. PeptiStar GMP Peptide Manufacturing Services Product and Services
Table 104. PeptiStar GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. PeptiStar Recent Developments/Updates
Table 106. PeptiStar Competitive Strengths & Weaknesses
Table 107. BCN Peptides Basic Information, Manufacturing Base and Competitors
Table 108. BCN Peptides Major Business
Table 109. BCN Peptides GMP Peptide Manufacturing Services Product and Services
Table 110. BCN Peptides GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. BCN Peptides Recent Developments/Updates
Table 112. BCN Peptides Competitive Strengths & Weaknesses
Table 113. Cambrex Basic Information, Manufacturing Base and Competitors
Table 114. Cambrex Major Business
Table 115. Cambrex GMP Peptide Manufacturing Services Product and Services
Table 116. Cambrex GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Cambrex Recent Developments/Updates
Table 118. Cambrex Competitive Strengths & Weaknesses
Table 119. Nippon Shokubai Basic Information, Manufacturing Base and Competitors
Table 120. Nippon Shokubai Major Business
Table 121. Nippon Shokubai GMP Peptide Manufacturing Services Product and Services
Table 122. Nippon Shokubai GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Nippon Shokubai Recent Developments/Updates
Table 124. Nippon Shokubai Competitive Strengths & Weaknesses
Table 125. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 126. ScinoPharm Major Business
Table 127. ScinoPharm GMP Peptide Manufacturing Services Product and Services
Table 128. ScinoPharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. ScinoPharm Recent Developments/Updates
Table 130. ScinoPharm Competitive Strengths & Weaknesses
Table 131. Chengdu Shengnuo Biopharm Basic Information, Manufacturing Base and Competitors
Table 132. Chengdu Shengnuo Biopharm Major Business
Table 133. Chengdu Shengnuo Biopharm GMP Peptide Manufacturing Services Product and Services
Table 134. Chengdu Shengnuo Biopharm GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Chengdu Shengnuo Biopharm Recent Developments/Updates
Table 136. Chengdu Shengnuo Biopharm Competitive Strengths & Weaknesses
Table 137. WuXi TIDES Basic Information, Manufacturing Base and Competitors
Table 138. WuXi TIDES Major Business
Table 139. WuXi TIDES GMP Peptide Manufacturing Services Product and Services
Table 140. WuXi TIDES GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. WuXi TIDES Recent Developments/Updates
Table 142. WuXi TIDES Competitive Strengths & Weaknesses
Table 143. Asymchem Basic Information, Manufacturing Base and Competitors
Table 144. Asymchem Major Business
Table 145. Asymchem GMP Peptide Manufacturing Services Product and Services
Table 146. Asymchem GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Asymchem Recent Developments/Updates
Table 148. Asymchem Competitive Strengths & Weaknesses
Table 149. Medtide Basic Information, Manufacturing Base and Competitors
Table 150. Medtide Major Business
Table 151. Medtide GMP Peptide Manufacturing Services Product and Services
Table 152. Medtide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Medtide Recent Developments/Updates
Table 154. Medtide Competitive Strengths & Weaknesses
Table 155. Jiuzhou Pharma Basic Information, Manufacturing Base and Competitors
Table 156. Jiuzhou Pharma Major Business
Table 157. Jiuzhou Pharma GMP Peptide Manufacturing Services Product and Services
Table 158. Jiuzhou Pharma GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Jiuzhou Pharma Recent Developments/Updates
Table 160. Jiuzhou Pharma Competitive Strengths & Weaknesses
Table 161. Hybio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 162. Hybio Pharmaceutical Major Business
Table 163. Hybio Pharmaceutical GMP Peptide Manufacturing Services Product and Services
Table 164. Hybio Pharmaceutical GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Hybio Pharmaceutical Recent Developments/Updates
Table 166. Hybio Pharmaceutical Competitive Strengths & Weaknesses
Table 167. JYMed Peptide Basic Information, Manufacturing Base and Competitors
Table 168. JYMed Peptide Major Business
Table 169. JYMed Peptide GMP Peptide Manufacturing Services Product and Services
Table 170. JYMed Peptide GMP Peptide Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. JYMed Peptide Recent Developments/Updates
Table 172. JYMed Peptide Competitive Strengths & Weaknesses
Table 173. Global Key Players of GMP Peptide Manufacturing Services Upstream (Raw Materials)
Table 174. Global GMP Peptide Manufacturing Services Typical Customers
LIST OF FIGURES
Figure 1. GMP Peptide Manufacturing Services Picture
Figure 2. World GMP Peptide Manufacturing Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GMP Peptide Manufacturing Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World GMP Peptide Manufacturing Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World GMP Peptide Manufacturing Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 13. GMP Peptide Manufacturing Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World GMP Peptide Manufacturing Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of GMP Peptide Manufacturing Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for GMP Peptide Manufacturing Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for GMP Peptide Manufacturing Services Markets in 2025
Figure 27. United States VS China: GMP Peptide Manufacturing Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: GMP Peptide Manufacturing Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World GMP Peptide Manufacturing Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World GMP Peptide Manufacturing Services Market Size Market Share by Type in 2025
Figure 31. Process Development
Figure 32. Clinical GMP Manufacturing
Figure 33. Commercial GMP Manufacturing
Figure 34. Other
Figure 35. World GMP Peptide Manufacturing Services Market Size Market Share by Type (2021-2032)
Figure 36. World GMP Peptide Manufacturing Services Market Size by Synthesis Technology, (USD Million), 2021 & 2025 & 2032
Figure 37. World GMP Peptide Manufacturing Services Market Size Market Share by Synthesis Technology in 2025
Figure 38. SPPS
Figure 39. LPPS
Figure 40. Hybrid Technology
Figure 41. World GMP Peptide Manufacturing Services Market Size Market Share by Synthesis Technology (2021-2032)
Figure 42. World GMP Peptide Manufacturing Services Market Size by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Figure 43. World GMP Peptide Manufacturing Services Market Size Market Share by Therapeutic Area in 2025
Figure 44. Metabolic Diseases
Figure 45. Oncology
Figure 46. Endocrine and Reproductive Health
Figure 47. Rare Diseases and Specialty Care
Figure 48. Others
Figure 49. World GMP Peptide Manufacturing Services Market Size Market Share by Therapeutic Area (2021-2032)
Figure 50. World GMP Peptide Manufacturing Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World GMP Peptide Manufacturing Services Market Size Market Share by Application in 2025
Figure 52. Pharmaceutical Companies
Figure 53. Biotechnology Companies
Figure 54. Academic and Research Institutions
Figure 55. Others
Figure 56. World GMP Peptide Manufacturing Services Market Size Market Share by Application (2021-2032)
Figure 57. GMP Peptide Manufacturing Services Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
Figure 1. GMP Peptide Manufacturing Services Picture
Figure 2. World GMP Peptide Manufacturing Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GMP Peptide Manufacturing Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World GMP Peptide Manufacturing Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World GMP Peptide Manufacturing Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company GMP Peptide Manufacturing Services Revenue (2021-2032) & (USD Million)
Figure 13. GMP Peptide Manufacturing Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World GMP Peptide Manufacturing Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India GMP Peptide Manufacturing Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of GMP Peptide Manufacturing Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for GMP Peptide Manufacturing Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for GMP Peptide Manufacturing Services Markets in 2025
Figure 27. United States VS China: GMP Peptide Manufacturing Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: GMP Peptide Manufacturing Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World GMP Peptide Manufacturing Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World GMP Peptide Manufacturing Services Market Size Market Share by Type in 2025
Figure 31. Process Development
Figure 32. Clinical GMP Manufacturing
Figure 33. Commercial GMP Manufacturing
Figure 34. Other
Figure 35. World GMP Peptide Manufacturing Services Market Size Market Share by Type (2021-2032)
Figure 36. World GMP Peptide Manufacturing Services Market Size by Synthesis Technology, (USD Million), 2021 & 2025 & 2032
Figure 37. World GMP Peptide Manufacturing Services Market Size Market Share by Synthesis Technology in 2025
Figure 38. SPPS
Figure 39. LPPS
Figure 40. Hybrid Technology
Figure 41. World GMP Peptide Manufacturing Services Market Size Market Share by Synthesis Technology (2021-2032)
Figure 42. World GMP Peptide Manufacturing Services Market Size by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Figure 43. World GMP Peptide Manufacturing Services Market Size Market Share by Therapeutic Area in 2025
Figure 44. Metabolic Diseases
Figure 45. Oncology
Figure 46. Endocrine and Reproductive Health
Figure 47. Rare Diseases and Specialty Care
Figure 48. Others
Figure 49. World GMP Peptide Manufacturing Services Market Size Market Share by Therapeutic Area (2021-2032)
Figure 50. World GMP Peptide Manufacturing Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World GMP Peptide Manufacturing Services Market Size Market Share by Application in 2025
Figure 52. Pharmaceutical Companies
Figure 53. Biotechnology Companies
Figure 54. Academic and Research Institutions
Figure 55. Others
Figure 56. World GMP Peptide Manufacturing Services Market Size Market Share by Application (2021-2032)
Figure 57. GMP Peptide Manufacturing Services Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
